Evidence map›Paper›PMID 40146319›Full record

ArticleGenetics2025

GWAS significance thresholds in large cohorts of European ancestry.

Evans K Cheruiyot, Tingyan Yang, Allan F McRae

Abstract read
In one paragraph

Article in Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Evans K CheruiyotInstitute of Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0002-6403-7967
Tingyan YangTranslational Neurogenomics Group, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Allan F McRaeInstitute of Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.

Funding

Australian Government
6 · The paper itself

Abstract

While the P-value threshold of 5.0×10-8 remains the standard for genome-wide association studies (GWAS) in humans and other species, it still needs to be updated to reflect the current era of large-scale GWAS, where tens of thousands of sample sizes are used to discover genetic associations at loci with smaller minor allele frequencies. In this study, we used a dataset of 348,501 individuals of European ancestry from the UK Biobank to determine the GWAS thresholds required for multiple testing corrections when considering rare and common variants in additive and dominant GWAS models. Additionally, we employed conditional and joint analysis to quantify the proportion of false significant hits in the GWAS results for 72 traits in the UK Biobank when applying the traditional GWAS cutoff vs our newly proposed P-value thresholds. Overall, the results indicate that the conventional GWAS significance threshold of 5.0×10-8 yields a false-positive rate of between 20% and 30% in GWAS studies that utilize large sample sizes and less common variants. Instead, a more stringent GWAS P-value threshold of 5.0×10-9 is needed when rare variants (with minor allele frequency > 0.1%) are included in the association test for both additive and dominance models within the European ancestry population. However, further validation across diverse datasets and study designs, is needed to evaluate the broader applicability of this proposed threshold.

Indexed as

Genome-Wide Association StudyWhite PeopleCohort StudiesGene FrequencyHumansModels, GeneticPolymorphism, Single NucleotideWhiteadditivedominancefalse discoveryGWASP-valuethresholdUK Biobank

Identifiers

PMID40146319
PMCPMC12059634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.